PRKCA and papillary glioneuronal tumor: SLC44A1 (solute carrier family 44)-PRKCA (PKCα) fusion oncogene was detected in papillary glioneuronal tumor with the rearrangement of chromosomes 9 and 17, thus leading to constitutive PKCα activation [32].